Investigators release Gogol-Center artistic director after questioningSociety & Culture May 24, 2:32
London may be among contenders for 2018 FIDE chess world championship — FIDESport May 24, 2:29
Putin begins talks with visiting Philippine leaderRussian Politics & Diplomacy May 24, 0:15
Mechanism of alerting on cyberattacks practically never used by US — spokespersonWorld May 23, 22:19
Putin praises work of Independent Public Anti-Doping CommissionSport May 23, 20:38
Russia needs expanding representation in global sports federations — ministerSport May 23, 20:21
Russian athletes must be trained for Olympics under certain geographic conditions — PutinSport May 23, 19:38
Final charges brought against Russian ex-economy minister UlyukayevBusiness & Economy May 23, 18:59
WADA delegation to visit Moscow this week to help with membership reinstatementSport May 23, 18:48
SAN ANTONIO, Texas and ZEEWOLDE, Netherlands, Feb. 4 /PRNewswire/ -- Mobile interoperability leader AirStrip® and Telenatal® have announced a strategic partnership to begin distributing AirStrip's Sense4Baby wireless fetal/maternal monitoring system in 13 European countries. Sense4Baby is used to perform remote maternal and fetal monitoring including for high-risk pregnancies. The monitoring system received a CE mark from the European Commission in 2013 for commercialization in remote settings including self-administration.
AirStrip and Telenatal will make Sense4Baby available in the Netherlands, Austria, Belgium, Denmark, France, Germany, Italy, Luxembourg, Norway, Spain, Sweden, Switzerland and Turkey. Established in 2007, Telenatal aims to provide additional care choices to women facing increased medical risk during pregnancy.
"Our goal is to help pregnant patients stay as comfortable as possible while ensuring they receive the highest-quality care at all times," said Telenatal CEO Marco van Elst. AirStrip and Sense4Baby enable remote monitoring that expectant mothers can easily operate themselves at home. Medical professionals are able to remotely monitor and assess the data anywhere and anytime. AirStrip is an established leader in mobile monitoring, and we look forward to bringing Sense4Baby to patients and clinicians."
"AirStrip has a long-standing commitment to maternal-fetal health and safety. Sense4Baby allows us to extend interoperability and mobility to out of hospital settings to promote better outcomes, safety, and convenience," said AirStrip President Matt Patterson, MD. "International demand for Sense4Baby is overwhelming. We are delighted to partner with Telenatal to begin addressing the demand throughout Europe."
AirStrip acquired the assets of Sense4Baby, Inc. in 2014. It received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for remote use by medical professionals and is pending FDA clearance for self-administration.
Tweet This: .@AirStripmHealth and Telenatal partner to launch #Sense4Baby in 13 European countries http://bit.ly/12a91UT
AirStrip® (www.airstrip.com) provides a complete, vendor- and data source-agnostic enterprise-wide clinical mobility solution, which enables clinicians to improve the health of individuals and populations. With deep clinical expertise and strong roots in mobile technology and data integration, AirStrip is empowering leading health systems globally as the industry continues to evolve at a rapid pace. Based in San Antonio, Texas, AirStrip allows health systems to unlock the full potential of their existing technology investments with a complete mobility solution that provides access to critical patient data across the care continuum. AirStrip is backed by investments from Dignity Health, St. Joseph Health, the Gary and Mary West Health Investment Fund, Sequoia Capital, Qualcomm, Inc., Leerink Partners, Hospital Corporation of America (HCA) and the Wellcome Trust. AirStrip's base of visionary clients includes HCA, Texas Health Resources, Tenet Healthcare, Dignity Health, St. Joseph Health and Ardent Health Services.
Chris Lato, AirStrip Media
Tel.: +1 (608) 219-72-31
Siobhan Nguyen, AirStrip Media
Tel.: +1 (617) 986-57-84